214.70MMarket Cap-5.34P/E (TTM)
7.195High6.900Low42.76KVolume7.000Open7.050Pre Close301.76KTurnover0.16%Turnover RatioLossP/E (Static)30.03MShares11.42052wk High6.91P/B192.90MFloat Cap6.88052wk Low--Dividend TTM26.98MShs Float28.970Historical High--Div YieldTTM4.18%Amplitude3.100Historical Low7.057Avg Price1Lot Size
Profound Medical Stock Forum
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
Profound Medical announced the U.S. Centers for Medicare and Medicaid Services (CMS) proposed a Category 1 CPT code for Transurethral Ultrasound Ablation (TULSA), effective January 1, 2025. This includes three physician codes for different procedural scenarios, introducing greater billing flexibility for pre and post-procedure visits.
TULSA will be recognize...
NEWS
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
Profound Medical Corp.'s TULSA procedure is gaining recognition as a mainstream treatment for prostate diseases, with 25 scientific research presentations this year alone. The clinical evidence showcases TULSA's efficacy in treating a diverse range of patients with localized prostate c...
No comment yet